Literature DB >> 8101187

Current issues in the pharmacologic management of obsessive compulsive disorder.

S A Rasmussen1, J L Eisen, M T Pato.   

Abstract

In spite of significant advances in the development of behavioral and pharmacologic strategies for the treatment of obsessive compulsive disorder, little is known about the comparative efficacy and safety of those treatments. In addition, questions about the dose and duration in maintenance treatment remain unknown. This article reviews current issues in the pharmacologic management of patients with obsessive compulsive disorder.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8101187

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


  8 in total

1.  Prediction of remission in obsessive compulsive disorder using a novel machine learning strategy.

Authors:  Kathleen D Askland; Sarah Garnaat; Nicholas J Sibrava; Christina L Boisseau; David Strong; Maria Mancebo; Benjamin Greenberg; Steve Rasmussen; Jane Eisen
Journal:  Int J Methods Psychiatr Res       Date:  2015-05-21       Impact factor: 4.035

Review 2.  A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.

Authors:  L L Carpenter; C J McDougle; C N Epperson; L H Price
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

Review 3.  A risk-benefit assessment of buspirone in the treatment of anxiety disorders.

Authors:  J C Pecknold
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

4.  Current Perspectives on the Diagnosis and Treatment of Double Depression.

Authors:  D J Hellerstein; S A Little
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

Review 5.  Obsessive-compulsive disorder. Diagnosis and management.

Authors:  R Ladouceur; M Freeston; F Gagnon
Journal:  Can Fam Physician       Date:  1996-06       Impact factor: 3.275

6.  Design and Rationale for a Randomized Controlled Trial Testing the Efficacy of Aerobic Exercise for Patients with Obsessive-Compulsive Disorder.

Authors:  Ana M Abrantes; Nicole McLaughlin; Benjamin D Greenberg; David R Strong; Deborah Riebe; Maria Mancebo; Steven Rasmussen; Julie Desaulniers; Richard A Brown
Journal:  Ment Health Phys Act       Date:  2012-06-30

7.  Obsessive-compulsive spectrum disorders.

Authors:  Andrea Allen; Audrey King; Eric Hollander
Journal:  Dialogues Clin Neurosci       Date:  2003-09       Impact factor: 5.986

8.  Effectiveness of Rajyoga meditation as an adjunct to first-line treatment in patients with obsessive compulsive disorder.

Authors:  Kiran Mehta; Shivangi Mehta; Harsh Chalana; Harjot Singh; Richa Ghay Thaman
Journal:  Indian J Psychiatry       Date:  2020-12-12       Impact factor: 1.759
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.